No. |
GO terms |
Targets |
# of targets |
p-value (EPT)↑ |
p-value (EPD) |
1 |
epinephrine binding |
ADRA2A;ADRA2C;ADRB2;ADRB3;ADRB1;ADRA2B |
6 |
1.6E-12 |
0.047 |
2 |
norepinephrine binding |
ADRB1;ADRA2A;ADRB2;ADRB3 |
4 |
2.9E-8 |
0.048 |
3 |
monoamine transmembrane transporter activity |
SLC6A4;SLC18A2;SLC6A2;SLC6A3 |
4 |
9.7E-8 |
0.039 |
4 |
alpha1-adrenergic receptor activity |
ADRA1A;ADRA1B;ADRA1D |
3 |
2.1E-6 |
0.04 |
5 |
alpha2-adrenergic receptor activity |
ADRA2A;ADRA2B;ADRA2C |
3 |
2.1E-6 |
0.043 |
6 |
dopamine binding |
ADRB2;DRD2;SLC6A3 |
3 |
9.4E-5 |
0.058 |
7 |
beta-adrenergic receptor activity |
ADRB1;ADRB3 |
2 |
0.00024 |
0.043 |
8 |
protein heterodimerization activity |
ADRB1;ADRA2A;ADRA1B;ADRA1A;ADRA2C |
5 |
0.0005 |
0.095 |
9 |
alpha-2A adrenergic receptor binding |
ADRB1;ADRA2C |
2 |
0.0017 |
0.041 |
10 |
primary amine oxidase activity |
MAOB;MAOA |
2 |
0.0017 |
0.076 |
11 |
alpha-1B adrenergic receptor binding |
ADRA2A |
1 |
0.011 |
0.04 |
12 |
cocaine binding |
SLC6A4 |
1 |
0.011 |
0.053 |
13 |
Ras guanyl-nucleotide exchange factor activity |
ADRB1 |
1 |
0.012 |
0.043 |
14 |
beta2-adrenergic receptor activity |
ADRB2 |
1 |
0.013 |
0.043 |
15 |
norepinephrine |
SLC6A2 |
1 |
0.013 |
0.066 |
16 |
potassium channel regulator activity |
ADRB2;DRD2 |
2 |
0.013 |
0.047 |
17 |
serotonin |
SLC6A4 |
1 |
0.014 |
0.058 |
18 |
trace-amine receptor activity |
TAAR1 |
1 |
0.015 |
0.028 |
19 |
dopamine transmembrane transporter activity |
SLC6A3 |
1 |
0.016 |
0.08 |
20 |
beta1-adrenergic receptor activity |
ADRB1 |
1 |
0.016 |
0.043 |
21 |
beta3-adrenergic receptor activity |
ADRB3 |
1 |
0.018 |
0.11 |
22 |
dopamine |
SLC6A3 |
1 |
0.019 |
0.08 |
23 |
heterotrimeric G-protein binding |
ADRA2A |
1 |
0.02 |
0.042 |
24 |
alpha-2C adrenergic receptor binding |
ADRA2A |
1 |
0.021 |
0.04 |
25 |
serotonin transmembrane transporter activity |
SLC6A4 |
1 |
0.021 |
0.05 |
26 |
flavin adenine dinucleotide binding |
MAOB;MAOA |
2 |
0.022 |
0.048 |
27 |
dopamine neurotransmitter receptor activity, coupled via Gi/Go |
DRD2 |
1 |
0.029 |
0.039 |
28 |
thioesterase binding |
ADRA2A |
1 |
0.047 |
0.041 |
29 |
protein homodimerization activity |
ADRA2A;ADRB2;ADRB3;ADRA2C |
4 |
0.047 |
0.16 |
30 |
Rab GTPase binding |
SLC6A4 |
1 |
0.052 |
0.047 |
31 |
serotonin binding |
MAOA |
1 |
0.075 |
0.049 |
32 |
drug binding |
ADRB2;DRD2 |
2 |
0.085 |
0.19 |
33 |
receptor signaling protein activity |
ADRB1 |
1 |
0.085 |
0.042 |
34 |
actin filament binding |
SLC6A4 |
1 |
0.097 |
0.043 |
35 |
PDZ domain binding |
ADRB1 |
1 |
0.14 |
0.041 |
36 |
G-protein coupled receptor activity |
TAAR1 |
1 |
0.29 |
0.058 |
37 |
electron carrier activity |
MAOB |
1 |
0.34 |
0.045 |
38 |
protein kinase binding |
ADRA2A |
1 |
0.48 |
0.089 |
39 |
identical protein binding |
DRD2 |
1 |
0.7 |
0.17 |